**Experiences of 30 Years in Right Trisectionectomy for Huge Liver Tumor**

Jing An Rui

[52] Castro-Perez R, Dopico-Reyes E, Acosta-Gonzalez LR. Minilaparoscopic-assisted transvaginal approach in benign liver lesions. *Rev Esp Enferm Dig.* 2010; 102: 357–64. [53] Berelavichus SV, Kriger AG, Starkov I, Shishin KV, Gorin DS, Poliakov IS. [Roboticassisted and laparoscopic hepatic resections for nonparasitic cysts of posterior liver

[54] Mazza OM, Fernandez DL, Pekolj J, *et al.* Management of nonparasitic hepatic cysts. *J Am*

[55] Koffron A, Rao S, Ferrario M, Abecassis M. Intrahepatic biliary cystadenoma: role of cyst fluid analysis and surgical management in the laparoscopic era. *Surgery*. 2004; 136: 926–

[56] Ishii K, Yoshida H, Taniai N, Moneta S, Kawano Y, Tajiri T. Infected hepatic cyst treated with percutaneous transhepatic drainage. *J Nippon Med Sch*. 2009; 76: 160–4.

[57] Ueda J, Yoshida H, Taniai N, Mineta S, Kawano Y, Uchida E. A case of spontaneous

[58] Gevers TJ, Chrispijn M, Wetzels JF, Drenth JP. Rationale and design of the RESOLVE trial: lanreotide as a volume reducing treatment for polycystic livers in patients with

[59] Temmerman F, Gevers T, Ho TA, *et al.* Safety and efficacy of different lanreotide doses in the treatment of polycystic liver disease: pooled analysis of individual patient data.

[60] Jeyarajah DR, Gonwa TA, Testa G, *et al.* Liver and kidney transplantation for polycys‐

[61] Benedetti E, Pirenne J, Troppmann C, *et al.* Combined liver and kidney transplantation.

[62] Pirenne J, Aerts R, Yoong K, *et al.* Liver transplantation for polycystic liver disease. *Liver*

[63] Smira G, Matei E, Gheorghe L, Popescu I. The MELD score exception for polycystic liver

[64] Kornasiewicz O, Dudek K, Bugajski M, Najnigier B, Krawczyk M. Choice of transplan‐ tation techniques and indications for liver transplantation in polycystic liver disease in patients with no signs of end-stage liver disease. *Transplant Proc.* 2008; 40: 1536–8. [65] Takei R, Ubara Y, Hoshino J, *et al.* Intravascular embolization therapy in patients with

[66] 66. Scheuerlein H, Rauchfuss F, Franke J, *et al*. Clinical symptoms and sonographic follow-up after surgical treatment of nonparasitic liver cysts. BMC Surgery. 2013;

[67] Swenson K, Seu P, Kinkhabwala M, et al. Liver transplantation for adult polycystic liver

autosomal dominant polycystic kidney disease. *BMC Nephrol.* 2012; 13: 17.

rupture of a simple hepatic cyst. *J Nippon Med Sch*. 2010; 77: 181–5.

segments]. *Khirurgiia (Mosk)* 2013; 14–9.

*Aliment Pharmacol Ther.* 2013; 38: 397–406.

tic disease. *Transplantation*. 1998; 66: 529–32.

disease. *Chirurgia (Bucur.)* 2013; 108: 418–21.

disease. Hepatology. 1998; 28: 412–5.

enlarged polycystic liver. *Am J Kidney Dis*. 2014; 63: 937–44.

*Transpl Int*. 1996; 9: 486–91.

*Transpl.* 2001; 7: 238–45.

13:42-49

*Coll Surg.* 2009; 209: 733–9.

282 Recent Advances in Liver Diseases and Surgery

36.

Additional information is available at the end of the chapter

http://dx.doi.org/10.5772/61175

#### **Abstract**

Hepatocellular carcinoma (HCC) is the fifth most common cancer in the world and the third leading cause of cancer-related deaths. Up to now, surgery remains to be the main curative strategy for hepatocellular carcinoma. In this article the author summa‐ rizes his experiences of 30 years in right trisectionectomy for huge liver tumor. A total of 459 primary liver cancer patients were hepatomized in author's group. Among them, 33 cases of right trisectionectomies were performed under continuous single in‐ terruption of the porta hepatis. The 1-, 3-, and 5-year survival rates were 71.9%, 40.6%, and 34.4%, respectively. The longest cancer-free survival of right trisectionectomy in our group is 26 years. In the author's another cohort, 51 patients underwent hepatec‐ tomy without allogeneic blood transfusion. Compared with the control group contain‐ ing 60 patients who underwent hepatectomy with allogeneic blood transfusion, the morbidity and recurrence rates in the group without allogeneic blood transfusion were significantly decreased (P < 0.05). Surgical anatomy study of the hepatic veins and case reports are also included in this article. Taken together, it is obvious that right trisectionectomy under continuous single interruption of the porta hepatis with‐ out allogeneic blood transfusion would benefit the patient with resectable huge HCC.

**Keywords:** primary liver cancer, right trisectionectomy, continuous single interrup‐ tion of the porta hepatis, surgical anatomy of hepatic veins, major hepatectomy with‐ out allogeneic blood transfusion
